Francisco Rodríguez‐Moranta

Bellvitge University Hospital — Spain

Biochemistry, Genetics and Molecular Biology · Life Sciences

34h-index3.8kcitations220works2.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(74), Microscopic Colitis(62), Colorectal Cancer Screening and Detection(53), Genetic factors in colorectal cancer(52), Gastric Cancer Management and Outcomes(21)

Publications216 total

Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced Colitis

Journal of Clinical Medicine·2026Open Access

GETECCU position paper on fragility, advanced age and inflammatory bowel disease

Gastroenterología y Hepatología (English Edition)·2025

Prevention of Tuberculosis in Patients Treated With Biological Therapies: 20 Years' Experience in a Specialized Tuberculosis Clinic in a Low-prevalence Country

3 cited

Clinical Infectious Diseases·2025· 3 cited

Documento de posicionamiento de GETECCU sobre fragilidad, edad avanzada y enfermedad inflamatoria intestinal

Gastroenterología y Hepatología·2025Open Access

Spanish Working Group in Crohn's Disease and Ulcerative Colitis (GETECCU) position paper for the management of non-perianal fistulizing Crohn’s disease

Gastroenterología y Hepatología (English Edition)·2025

Natural history, immunological and genetic characteristics of preclinical inflammatory bowel disease (EARLY): study protocol for a prospective cohort study

2 cited

Therapeutic Advances in Gastroenterology·2025· 2 citedOpen Access

Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis on the use of Telemedicine in Inflammatory Bowel Disease

1 cited

Gastroenterología y Hepatología (English Edition)·2025· 1 cited

Gene-Specific Detection Rate of Adenomas and Advanced Adenomas in Lynch Syndrome

5 cited

Gastroenterology·2025· 5 cited

Documento de posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) para el manejo de la enfermedad fistulizante no perianal en la enfermedad de Crohn

Gastroenterología y Hepatología·2025

Spanish Working Group in Crohn’s Disease and Ulcerative Colitis (GETECCU) position paper on cardiovascular disease in patients with inflammatory bowel disease

4 cited

Gastroenterología y Hepatología (English Edition)·2025· 4 cited

SIBO: ¿una patología cada vez más frecuente?

FMC - Formación Médica Continuada en Atención Primaria·2025

Position statement of the Spanish Society of Primary Care Physicians (SEMERGEN) and Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the management of inflammatory bowel disease in Primary Care

Gastroenterología y Hepatología (English Edition)·2025Open Access

Documento de posicionamiento de la Sociedad Española de Médicos de Atención Primaria (SEMERGEN) y del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el manejo de la enfermedad inflamatoria intestinal en atención primaria

Gastroenterología y Hepatología·2025Open Access

Medicina de Familia SEMERGEN·2025

Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU

3 cited

United European Gastroenterology Journal·2025· 3 citedOpen Access

P0936 Switch from intravenous to subcutaneous infliximab: first subcutaneous dose and cumulative area under curve

Journal of Crohn s and Colitis·2025Open Access

P-40 - LEISHMANIASIS EN PACIENTES CON ENFERMEDAD INFLAMATORIA INTESTINAL: ESTUDIO MULTICÉNTRICO NACIONAL DEL GETECCU

Gastroenterología y Hepatología·2025

P1016 Leishmaniasis in patients with inflammatory bowel disease: a national multicenter study of GETECCU

Journal of Crohn s and Colitis·2025

P0609 Real-world short and long-term effectiveness of risankizumab in refractory Crohn’s disease: RISANCROHN study from the ENEIDA Registry

1 cited

Journal of Crohn s and Colitis·2025· 1 citedOpen Access

P-33 - TASA DE RESPUESTA Y FACTORES PREDICTORES DE RESPUESTA AL TRATAMIENTO CON CORTICOIDES INTRAVENOSOS EN COLITIS INMUNOMEDIADAS MODERADAS-GRAVES: ESTUDIO REGIC PROMOVIDO POR GETECCU

Gastroenterología y Hepatología·2025

page 1 of 11Next →

Frequent Co-authors

Jordi Guardiola(20), Vı́ctor Moreno(18), Virgı́nia Piñol(10), Antoni Castells(10), Lorena Rodríguez‐Alonso(10), Luís Bujanda(9), Xavier Bessa(8), Triana Lobatón(8), Joaquín Cubiella(8), Gemma Binefa(7), Javier de(7), Rodrigo Jover(7), Francesc Balaguer(7), Elisabet Guinó(6), Jaume Boadas(6), Xavier Sanjuán(6), Gabriel Capellá(6), María Pellisé(6), Fernando Fernández‐Bañares(6), Javier P. Gisbert(6)